Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This ...

Telegraph investigation finds ‘critical’ information missing from early warnings about AstraZeneca vaccine’s side effects ...

AstraZeneca scrapped plans for a £450 million UK vaccine plant after rejecting a £78 million government offer, citing ...

AstraZeneca’s manufacturing will-they-won’t-they within its home country has swung back firmly toward the "they won’t" camp ...

January closed with two record high temps, as the first month of the year continues to heat up faster than any other in Minnesota Pharmaceutical company AstraZeneca on Friday cancelled a planned ...

The Financial Times leads on AstraZeneca's decision to scrap plans for a new vaccine manufacturing plant in Liverpool, calling it "a blow to the government's growth agenda". The paper says ...

AstraZeneca Plc abandoned plans to invest £450 million ($558 million) in a UK vaccine manufacturing plant, following protracted wrangling with the new Labour government over the level of state funding ...

LONDON, Jan 31 (Reuters) - AstraZeneca (AZN.L), opens new tab on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in northern England ...

The NHS spring booster campaign will offer jabs to limited groups of vulnerable patients from 1 April. More than 9.7 million ...

LONDON (AP) — Pharmaceutical company AstraZeneca on Friday cancelled a planned 450 million-pound ($560 million) investment in a vaccine manufacturing plant in northwest England, blaming the new ...